Vonoprazan-minocycline dual therapy as a first-line treatment of <i>Helicobacter pylori</i> infection compared with empirical bismuth-containing quadruple therapy. [PDF]
Ther Adv GastroenterolLi M +5 more
europepmc +1 more source
In vitro susceptibility testing of Trichomonas gallinae strains to proton pump inhibitors and nitroimidazoles. [PDF]
Sci RepKerek Á +6 more
europepmc +1 more source
Study to Establish the Relationship between Rabeprazole (PPI) and Acute Interstitial Nephritis (AIN). [PDF]
J Pharm Bioallied SciBapurao B, Pathak S, Ambad RS.
europepmc +1 more source
Impact of Acid Suppressants on the Development of <i>Clostridioides difficile</i> Infection and Possible Preventive Effects of Probiotic Formulations. [PDF]
Infect Drug ResistShiraishi C, Kato H, Iwamoto T.
europepmc +1 more source
Acid peptic disorder compass: An Indian expert consensus on comprehensive management. [PDF]
World J Gastrointest Pharmacol TherSinha SK +14 more
europepmc +1 more source
Assessment of Burden of Partial Response to Standard Doses of Proton Pump Inhibitors in Patients with Clinically Diagnosed Gastroesophageal Reflux Disease: A Real-World Evidence Study in India. [PDF]
Drugs Real World OutcomesGarje Y +11 more
europepmc +1 more source
New Therapeutic Potential of Potassium-Competitive Acid Blockers in the Management of Refractory Gastroesophageal Reflux Disease. [PDF]
Korean J Helicobacter Up Gastrointest ResRyu DG, Choi CW.
europepmc +1 more source
Vonoprazan-amoxicillin dual therapy vs. proton pump inhibitor based dual therapy for Helicobacter pylori eradication: a meta-analysis. [PDF]
Front Med (Lausanne)Lv Y, Zhou HH, Sun JG, Qin Y, Zhou BG.
europepmc +1 more source
Association between proton pump inhibitor use and the risk of myocardial infarction: A cross-sectional study based on NHANES 2007 to 2018. [PDF]
Medicine (Baltimore)Zhang W, Yuan Z, Zhou J.
europepmc +1 more source